Entrada Therapeutics
$13.15
5
-$0.33-2.45% Today
Statistics
Day High
13.53
Day Low
12.8
52W High
13.66
52W Low
4.93
Volume
177,131
Avg. Volume
226,800
Mkt Cap
502.58M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-1.0191
Actual EPS
N/A
Financials
31.13%Profit Margin
Profitable421.56MRevenue
131.25MNet Income
Analyst Ratings
$20.00Average Price Target
The highest estimate is 20.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TRDA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sarepta Therapeutics
SRPT
Mkt Cap2.51B
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Arrowhead Pharmaceuticals
ARWR
Mkt Cap5.86B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
PTC Therapeutics
PTCT
Mkt Cap5.4B
Wave Life Sciences
WVE
Mkt Cap1.44B
About
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Show more...
CEO
Mr. Dipal Doshi
Employees
183
Country
US
ISIN
US29384C1080
Listings
0 Comments
Share your thoughts
FAQ
What is Entrada Therapeutics stock price today?▼
The current price of TRDA is $13.15 USD — it has decreased by -2.45% in the past 24 hours. Watch Entrada Therapeutics stock price performance more closely on the chart.
What is Entrada Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Entrada Therapeutics stocks are traded under the ticker TRDA.
Is Entrada Therapeutics stock price growing?▼
TRDA stock has risen by +6.82% compared to the previous week, the month change is a +12.59% rise, over the last year Entrada Therapeutics has showed a +49.43% increase.
What is Entrada Therapeutics market cap?▼
Today Entrada Therapeutics has the market capitalization of 502.58M
When is the next Entrada Therapeutics earnings date?▼
Entrada Therapeutics is going to release the next earnings report on May 07, 2026.
What were Entrada Therapeutics earnings last quarter?▼
TRDA earnings for the last quarter are -0.94 USD per share, whereas the estimation was -1.15 USD resulting in a +18.28% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Entrada Therapeutics revenue for the last year?▼
Entrada Therapeutics revenue for the last year amounts to 421.56M USD.
What is Entrada Therapeutics net income for the last year?▼
TRDA net income for the last year is 131.25M USD.
How many employees does Entrada Therapeutics have?▼
As of April 02, 2026, the company has 183 employees.
In which sector is Entrada Therapeutics located?▼
Entrada Therapeutics operates in the Health Care sector.
When did Entrada Therapeutics complete a stock split?▼
Entrada Therapeutics has not had any recent stock splits.
Where is Entrada Therapeutics headquartered?▼
Entrada Therapeutics is headquartered in Boston, US.